Transient erythroid hypoplasia in a patient on long-term co-trimoxazole therapy
Open Access
- 1 April 1974
- journal article
- case report
- Published by Oxford University Press (OUP)
- Vol. 50 (582) , 235-237
- https://doi.org/10.1136/pgmj.50.582.235
Abstract
Summary: The occurrence of isolated erythroid hypoplasia in a patient on long-term treatment with co-trimoxazole is described. It is suggested that this haematological complication, which has not been previously reported, was due to hypersensitivity to the sulphonamide component.Keywords
This publication has 17 references indexed in Scilit:
- EFFECT OF CO-TRIMOXAZOLE ON PHENYLALANINE METABOLISMThe Lancet, 1973
- Toxicity of Trimethoprim-Sulphamethoxazole in Patients with Megaloblastic HaemopoiesisBMJ, 1972
- Trimethoprim and sulphamethoxazole.BMJ, 1971
- Agranulocytosis associated with trimethoprim-sulphamethoxazole.BMJ, 1971
- Leucopenia Associated with Trimethoprim-Sulphamethoxazole after Renal TransplantationBMJ, 1971
- Haematological changes in a patient on long-term treatment with a trimethoprim-sulphonamide combinationPublished by Oxford University Press (OUP) ,1970
- Drug NeutropeniaBMJ, 1970
- Neutropenia after trimethoprism-sulphamethoxazole for bronchitis.BMJ, 1969
- Agranulocytosis after trimethoprim and sulphamethoxazole.BMJ, 1969
- Trimethoprim: laboratory and clinical studiesJournal of Clinical Pathology, 1968